In AD, an excess of ROS may be produced by mitochondrial dysfunction, aggregation of Aβ proteins, phosphorylation and polymerization of tau and/or anomalous buildup of transition metals fostering the progression of the disease [92]. This evidence concerns the gene MAPT and Alzheimer disease.